Claritin Tablet
NDC Package 85237-1630-4
Package Information
Claritin (loratadine) tablets is a medication an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies. This formulation utilizes a tablet delivery system. Marketed by Select Consumer Group, this product is identified by NDC 85237-1630 and is authorized under FDA application ANDA075209.
Identification & Billing
- RxCUI: 206805 - Claritin 24HR Allergy 10 MG Oral Tablet
- RxCUI: 206805 - loratadine 10 MG Oral Tablet [Claritin]
- RxCUI: 206805 - Claritin 10 MG 24 HR Oral Tablet
- RxCUI: 206805 - Claritin 10 MG Oral Tablet
- RxCUI: 311372 - loratadine 10 MG 24HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85237 - Select Consumer Group
- 85237-1630 - Claritin
- 85237-1630-4 - 25 POUCH in 1 BOX, UNIT-DOSE / 1 TABLET in 1 POUCH
- 85237-1630 - Claritin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (85237-1630). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85237-1630-4 identifies a specific commercial package of 25 pouch in 1 box, unit-dose / 1 tablet in 1 pouch of Claritin, a human over the counter drug labeled by Select Consumer Group. This tablet is formulated for oral use and contains loratadine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Select Consumer Group on December 01, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies. It is also used to relieve itching from hives. Loratadine does not prevent hives or prevent/treat a serious allergic reaction (anaphylaxis). Therefore, if your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use loratadine in place of your epinephrine. If you are self-treating with this medication, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. (See also Precautions section.) If you are using the tablets or capsules, do not use in children younger than 6 years unless directed by the doctor. If you are using the liquid or chewable tablets, do not use in children younger than 2 years unless directed by the doctor.
How is this Select Consumer Group product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85237163004. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
